Summary
Plasma concentrations of L(+)pseudoephedrine administered in clinically used dosages were determined by gas liquid chromatography using a nitrogen sensitive detector. They were measured after administration of an immediate release formulation (Sudafed) given in either a single dose of 180 mg, or three divided doses of 60 mg, and also after administration of two different sustained release preparations containing 180 mg. Ten subjects each received five treatment regimes, administration being ordered in a balanced design based on 2 five sided Latin squares. Significant differences were found between plasma concentrations and rates of urinary excretion of L(+)pseudoephedrine following administration of the different preparations. Peak plasma concentrations were greatest after 180 mg of the immediate release preparation while more sustained elevations of concentration followed administration of both sustained release preparations and the immediate release preparation in repeated doses. Despite these differences in plasma concentration significant differences in heart rate, blood pressure, or subjective ratings of mental state rarely occured, and the reasons for this are discussed. In a second study, one of the sustained release preparations was administered to 10 subjects at a dose of 180 mg twice daily for two weeks, and plasma concentrations and effects were measured. L(+)pseudoephedrine plasma levels reached a plateau in 3 days producing increased heart rate initially insomnia occurred but this disappeared after 3 days.
Similar content being viewed by others
References
Bye, C., Dewsbury, D., Peck, A.W.: Effects on the human central nervous system of two isomers of ephedrine and triprolidine, and their interaction. Brit.J.clin.Pharmacol.1 71–78 (1974)
Cummins, L.M., Fourier, M.J.: GLC determination of pseudoephedrine and related ephedrines in serum as the heptafluorobutyryl derivates. Anal. Lett.2 403–409 (1969)
Dollery, C.T.: Pharmacokinetics — Master or Servant? Europ.J.clin.Pharmacol.6 1–2 (1973)
Kuntzman, R.G., Tsai, I., Brand, L., Mark, L.C.: The influence of urinary pH on the half-life of pseudoephedrine in man and dog and a sensitive assay for its determination in human plasma. Clin. Pharmacol. Ther.12 62–67 (1971)
Norris, H.: The actions of sedatives on brain stem oculomotor systems in man. Neuropharmacology10 181–191 (1971)
Wilkinson, G.R., Beckett, A.H.: Absorptions, Metabolism and Excretions of the Ephedrines in man. I. The influence of urinary pH and urine volume output. J. Pharmacol. exp. Ther.162 139–147 (1968)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bye, C., Hill, H.M., Hughes, D.T.D. et al. A comparison of plasma levels of L(+) pseudoephedrine following different formulations, and their relation to cardiovascular and subjective effects in man. Eur J Clin Pharmacol 8, 47–53 (1975). https://doi.org/10.1007/BF00616414
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00616414